Adrenal cortical myelolipoma
ICD-10 D35.0 · ICD-11 2F37.Y&XA0NE9&XH17C5

Treatment of Adrenal Cortical Myelolipoma in Poorly Controlled Congenital Adrenal Hyperplasia

Adrenal cortical myelolipoma presenting as large or bilateral lesions in the context of poorly controlled congenital adrenal hyperplasia (CAH) represents a distinct clinical situation. Patients with large or bilateral myelolipomas should be evaluated for an underlying diagnosis of CAH, as inadequate hormonal control may drive adrenal pathology. Both conditions must be addressed together when planning management.

In selected patients with poorly controlled CAH and adrenal myelolipomas, a surgical approach targeting the adrenal glands may be considered — though this is reserved for specific circumstances and requires thorough evaluation before proceeding.
Full indications, decision criteria, and sequencing are detailed in the complete protocol ↓

References

  • Bilateral adrenalectomy is occasionally used in poorly controlled congenital adrenal hyperplasia, sometimes with concomitant bilateral adrenal myelolipomas.
  • Patients with large or bilateral myelolipomas, or both, should be investigated for a possibility of congenital adrenal hyperplasia, with measurement of 17OHP concentrations.
  • Since adrenal rest tumours, especially in the testicles, might impair fertility, surgical removal of adrenal myelolipomas in congenital adrenal hyperplasia should only be done after careful consideration.
View source ↗